Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 15, 2019
Inventiva - Q1 2019 Financial Information and Corporate Business Update
Daix (France), May 15, 2019 – Inventiva (IVA.NX), a clinical-stage biopharmaceutical company developing oral small molecule therapies for the treatment of diseases in the areas ...
May 14, 2019
Molecular Templates to Present at the Oppenheimer New York Oncology Insight Summit and the UBS Global Healthcare Conference
AUSTIN, Texas, May 14, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered ...
May 14, 2019
Acer Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
NEWTON, Mass., May 14, 2019 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
May 14, 2019
TRACON Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
SAN DIEGO, May 14, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
May 14, 2019
Vermillion Reports First Quarter 2019 Financial Results
AUSTIN, Texas, May 14, 2019 (GLOBE NEWSWIRE) -- Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today reported its financial results ...
May 14, 2019
Chiasma and Lonza Announce Progression of Oral Octreotide Capsules Development and Definitive Commercial Supply Agreement
WALTHAM, Mass. and BASEL, Switzerland, May 14, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients ...
May 14, 2019
electroCore Announces First Quarter 2019 Financial Results
BASKING RIDGE, N.J., May 14, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (ECOR), a commercial-stage bioelectronic medicine company, today announced first quarter 2019 financial results and ...
May 14, 2019
OncoCyte Provides Corporate Update and Reports First Quarter 2019 Financial Results
ALAMEDA, Calif., May 14, 2019 (GLOBE NEWSWIRE) -- OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the early detection of lung ...
May 14, 2019
Novus Therapeutics Reports First Quarter 2019 Financial Results
IRVINE, Calif.--(BUSINESS WIRE)--Novus Therapeutics, Inc. (NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), ...
May 14, 2019
Altimmune Announces First Quarter 2019 Financial Results and Provides a Business Update
GAITHERSBURG, Md., May 14, 2019 (GLOBE NEWSWIRE) -- Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced financial results for the first quarter ended March ...
May 14, 2019
Inspire Medical Systems, Inc. Announces Publication Demonstrating Effectiveness of Inspire Therapy in Treating Obstructive Sleep Apnea in Medicare-aged Patients
MINNEAPOLIS, May 14, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative ...
May 14, 2019
Molecular Templates, Inc. Reports First Quarter 2019 Financial Results
AUSTIN, Texas, May 13, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and ...
May 14, 2019
aTyr Pharma Announces First Quarter 2019 Results and Provides Corporate Update
SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based ...
May 14, 2019
CorMedix Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
BERKELEY HEIGHTS, N.J., May 13, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...
May 14, 2019
Equillium Reports First Quarter 2019 Financial Results and Recent Highlights
LA JOLLA, Calif., May 13, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to ...
May 14, 2019
Zealand Pharma achieves primary and all key secondary endpoints in confirmatory Phase 3 trial with dasiglucagon for severe hypoglycemia
Copenhagen, May 14, 2019 – Zealand Pharma A/S (“Zealand”) (ZEAL), a Copenhagen-based biotechnology company focused on the discovery and development of innovative peptide-based medicines, announces ...
May 14, 2019
Kamada Reports Financial Results for First Quarter of 2019
REHOVOT, Israel, May 14, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq: KMDA; TASE: KMDA.TA), a plasma-derived protein therapeutics company, today announced financial results for the ...
May 14, 2019
Neovasc Announces Private Placement of Convertible Debt and Equity for Gross Proceeds of US$11.5 Million
VANCOUVER, May 14, 2019 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NVCN)(NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies ...
May 14, 2019
BioLineRx Reports First Quarter 2019 Financial Results and Provides Corporate Update
TEL AVIV, Israel, May 14, 2019 /PRNewswire/ -- BioLineRx Ltd. (BLRX) (BLRX), a clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for ...
May 14, 2019
InspireMD Announces First Quarter 2019 Financial Results
TEL AVIV, Israel, May 14, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention ...
Page 26 of 169